Tier 3 — preclinical

eIF5A hypusination, boosted by dietary spermidine, protects from premature brain aging and mitochondrial dysfunction

YongTian Liang, Chengji Piao, Christine B Beuschel, David Toppe, Laxmikanth Kollipara, Boris Bogdanow, Marta Maglione, Janine Lützkendorf, Jason Chun Kit See, Sheng Huang, Tim O F Conrad, Ulrich Kintscher, Frank Madeo, Fan Liu, Albert Sickmann, Stephan J Sigrist

Cell Reports 2021 35(2):108941

Bibliography

PubMed: PMID 33852845
DOI: 10.1016/j.celrep.2021.108941
Competing interests: Frank Madeo and Stephan J Sigrist disclosed equity interests in The Longevity Labs.

Study snapshot

Design	Preclinical genetic and nutritional mechanistic study
Model	Aging Drosophila brain and related molecular systems
Sample	Multiple Drosophila genetic and dietary experimental cohorts
Intervention	Dietary spermidine and genetic manipulation of eIF5A hypusination
Duration	Ageing experiments across life stages; varies by experiment
Endpoints	eIF5A hypusination; Mitochondrial respiration; Locomotion; Memory formation; Brain aging

What the study showed, in plain terms

This companion Cell Reports study showed that dietary spermidine can boost eIF5A hypusination in the aging fly brain, preserving mitochondrial function and aspects of behavior and memory.

Key findings

The study strengthens eIF5A hypusination as a conserved mechanistic link between spermidine and mitochondrial/brain aging. It does not establish cognitive benefit in humans.

What this study can and cannot tell us

The causal experiments are preclinical, primarily in Drosophila. Translation to human dosing and clinical outcomes remains unproven.

Editorial review

Reviewed by the Biohack Blueprint research team

Khaled Mahmoud